H&R GmbH & Co. KGaA Publishes Interim Report for First Half of 2024

H&R GmbH & Co. KGaA has released its interim report for the first half of 2024, confirming recovered business figures. Sales revenues reached €675.6 million, while operating earnings (EBITDA) slightly increased to €41.1 million compared to €39.4 million in the same period last year. However, the consolidated net income attributable to shareholders decreased, closing at €2.8 million, down from €3.7 million in H1 2023.

During this period, the company’s EBIT was €11.7 million, and earnings per share stood at €0.07, a slight decline from €0.10 the previous year. Despite these changes, H&R KGaA maintained its full-year EBITDA forecast between €90.0 million and €110.0 million.

The ChemPharm REFINING and ChemPharm SALES segments noted minor reductions in sales revenues, while the PLASTICS segment followed a similar trend. Operating cash flow and free cash flow both saw significant declines, with operative cash flow falling to €5.5 million and free cash flow at -€18.5 million in H1 2024.